Works matching IS 1742464X AND DT 2022 AND VI 289 AND IP 5

Results: 14

Cancer epigenetics: promises and pitfalls for cancer therapy.

Published in:

FEBS Journal, 2022, v. 289, n. 5, p. 1156, doi. 10.1111/febs.16395

By:

Skourti, Eleni;
Dhillon, Paraminder

Publication type:

Article

EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms.

Published in:

FEBS Journal, 2022, v. 289, n. 5, p. 1329, doi. 10.1111/febs.16334

By:

Nachiyappan, Alamelu;
Gupta, Neelima;
Taneja, Reshma

Publication type:

Article

Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.

Published in:: FEBS Journal, 2022, v. 289, n. 5, p. 1302, doi. 10.1111/febs.16032
Publication type:: Article

Epithelial‐to‐mesenchymal‐like transition events in melanoma.

Published in:

FEBS Journal, 2022, v. 289, n. 5, p. 1352, doi. 10.1111/febs.16021

By:

Pedri, Dennis;
Karras, Panagiotis;
Landeloos, Ewout;
Marine, Jean‐Christophe;
Rambow, Florian

Publication type:

Article

Table of Contents.

Published in:: FEBS Journal, 2022, v. 289, n. 5, p. 1369, doi. 10.1111/febs.15976
Publication type:: Article

Issue Information.

Published in:: FEBS Journal, 2022, v. 289, n. 5, p. 1153, doi. 10.1111/febs.15975
Publication type:: Article

Therapeutic targeting of chromatin: status and opportunities.

Published in:

FEBS Journal, 2022, v. 289, n. 5, p. 1276, doi. 10.1111/febs.15966

By:

Siklos, Marton;
Kubicek, Stefan

Publication type:

Article

Transposable element regulation and expression in cancer.

Published in:

FEBS Journal, 2022, v. 289, n. 5, p. 1160, doi. 10.1111/febs.15722

By:

Grundy, Erin E.;
Diab, Noor;
Chiappinelli, Katherine B.

Publication type:

Article

The duality of PRDM proteins: epigenetic and structural perspectives.

Published in:

FEBS Journal, 2022, v. 289, n. 5, p. 1256, doi. 10.1111/febs.15844

By:

Di Tullio, Federico;
Schwarz, Megan;
Zorgati, Habiba;
Mzoughi, Slim;
Guccione, Ernesto

Publication type:

Article

Physical mechanisms of chromatin spatial organization.

Published in:

FEBS Journal, 2022, v. 289, n. 5, p. 1180, doi. 10.1111/febs.15762

By:

Chiariello, Andrea M.;
Bianco, Simona;
Esposito, Andrea;
Fiorillo, Luca;
Conte, Mattia;
Irani, Ehsan;
Musella, Francesco;
Abraham, Alex;
Prisco, Antonella;
Nicodemi, Mario

Publication type:

Article

Clinical advances in targeting epigenetics for cancer therapy.

Published in:

FEBS Journal, 2022, v. 289, n. 5, p. 1214, doi. 10.1111/febs.15750

By:

Feng, Shengrui;
De Carvalho, Daniel D.

Publication type:

Article

The transcriptional regulation of normal and malignant blood cell development.

Published in:

FEBS Journal, 2022, v. 289, n. 5, p. 1240, doi. 10.1111/febs.15735

By:

Edginton‐White, Benjamin;
Bonifer, Constanze

Publication type:

Article

Oncohistones: a roadmap to stalled development.

Published in:

FEBS Journal, 2022, v. 289, n. 5, p. 1315, doi. 10.1111/febs.15963

By:

Deshmukh, Shriya;
Ptack, Adam;
Krug, Brian;
Jabado, Nada

Publication type:

Article

Mass spectrometry‐based characterization of histones in clinical samples: applications, progress, and challenges.

Published in:

FEBS Journal, 2022, v. 289, n. 5, p. 1191, doi. 10.1111/febs.15707

By:

Noberini, Roberta;
Robusti, Giulia;
Bonaldi, Tiziana

Publication type:

Article